NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Plaque psoriasis
Date of first enrollment	10/06/2013
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : M801801 INN of investigational material : Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational material : Proper quantity once a day control material(s) Generic name etc : Betamethasone butyrate propionate ointment INN of investigational material : Therapeutic category code : 264 Analgesics, anti-itchings, astrigents and anti-inflammatory agents Dosage and Administration for Investigational material : Proper quantity once a day Generic name etc : Maxacalcitol Ointment INN of investigational material : Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational material : Proper quantity twice a day

Outcome(s)

Primary Outcome	severity of plaque psoriasis
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 16age old
Age maximum	Not applicable
Gender	Both
Include criteria	Patients diagnosed with plaque psoriasis Outpatient
Exclude criteria